Wine, research and cardiovascular disease: Instructions for use

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages 242-247

  Bertelli, Alberto A E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiovascular disease; Study design; Wine

Indexed keywords

ANTIOXIDANT; CAFFEIC ACID; HYDROXYTYROSOL; OSELTAMIVIR; PHENOL; RESVERATROL; SHIKIMIC ACID;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; CARDIOVASCULAR DISEASE; HUMAN; IN VITRO SELECTION; IN VIVO STUDY; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; WINE; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLANT EXTRACTS; RATS; RESEARCH DESIGN; STILBENES; WINE;

EID: 36049005676     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.04.006     Document Type: Review

References (80)

1. Naissaides M., Mamo J.C.L., James A.P., and Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis 185 (2006) 438-445
2. Norata G.D., Marchesi P., Passamonti S., et al. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 191 (2007) 265-271
3. Blanco-Colio L.M., Muñoz-García B., Martín-Ventura J.L., et al. Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. Atherosclerosis 192 (2007) 335-341
4. Pignatelli P., Ghiselli A., Buchetti B., et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 (2006) 77-83
5. Waterhouse A.L. Wine Phenolics. Ann N Y Acad Sci 957 (2002) 21-36
6. Ruidavets J.B., Teissedre P.L., Ferrières J., Carando S., Bougard G., and Cabanis J.C. Catechin in the Mediterranean diet: vegetable, fruit or wine?. Atherosclerosis 153 (2000) 107-117
7. Arts I.C.W., Hollman P.C.H., Feskens E.J.M., Bas Bueno de Mesquita H., and Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 74 (2001) 227-232
8. Knekt P., Kumpulainen J., Järvinen R., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76 (2002) 560-568
9. Shishodia S, Aggarawal BB, Resveratrol, a polyphenol for all seasons In: Resveratrol in health, Disease, CRC Press, 2006, pp. 1-15.
10. Tokusoglu O., Ünal M.K., and Yemis F. Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J Agric Food Chem 53 (2005) 5003-5009
11. Wang Y., Catana F., Yang Y., Roderick R., and van Breemen R.B. An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice and in wine. J Agric Food Chem 50 (2002) 431-435
12. Meng X., Maliakal P., Lu H., Lee M.J., and Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 52 (2004) 935-942
13. Lamuela-Raventós R.M., and Waterhouse A.L. Occurrence of resveratrol in selected California wines by a new HPLC method. J Agric Food Chem 41 (1993) 521-523
14. Chu Q., O'Dwyer M., and Zeece M.G. Direct analysis of resveratrol in wine by Micel capillary electrophoresis. J Agric Food Chem 46 (1998) 509-513
15. Mattivi F. Solid phase extraction of trans-resveratrol form wines for HPLC analysis. Z Lebensm Unters Forsch 196 (1993) 522-525
16. Goldberg D.M., Karumanchiri A., Ng E., et al. Direct gas chromatographic-mass spectrometric method to assay cis-resveratrol in wines: preliminary survey of its concentration in commercial wines. J Agric Food Chem 43 (1995) 1245-1250
17. Jeandet P., Bessis R., Maume B.F., Meunier P., Peyron D., and Trollat P. Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem 43 (1995) 316-319
18. Vrhovsek U., Wendelin S., and Eder R. Effects of various vinification techniques on the concentration of cis-and trans-resveratrol and resveratrol glucoside isomers in wine. Am J Enol Vitic 48 (1997) 214-219
19. Corder R., Mullen W., Khan N.Q., et al. Red wine procyanidins and vascular health. Nature 444 (2006) 566
20. Muller C.J., and Fugelsang K.C. Red wine but not white: the importance of fully characterizing wines used in health studies. Am J Clin Nutr 66 (1997) 447-451
21. Kroon P.A., Clifford M.N., Crozier A., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr 80 (2004) 15-21
22. Bertelli AAE. Pharmacokinetics and metabolism of resveratrol. In: Resveratrol in health and Disease, CRC Press, 2006, pp. 631-647.
23. Horn T.L., Cwik M.J., Morrissey R.L., et al. Oncogenicity evaluation of resveratrol in p53 knockout mice. Food Chem Toxicol 45 (2007) 55-63
24. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36 (2003) 79-87
25. Bertelli A.A.E., Giovannini L., Stradi R., Bertelli A., and Tillement J.P. Plasma, urine and tissue levels of trans-a and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue Reac 18 (1996) 67-71
26. Ferrero M.E., Bertelli A.A.E., Fulgenzi A., et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 68 (1998) 1208-1214
27. Teel R.W., and Huynh H. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett 133 (1998) 135-141
28. Leikert J.F., Räthel T.R., Wohlfart P., et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106 (2002) 1614-1617
29. Gu J., Wang C.Q., Fan H.H., et al. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J Cardiovasc Pharmacol 47 (2006) 711-721
30. Zini R., Morin C., Bertelli A., Bertelli A.A.E., and Tillement J.P. Resveratrol-induced limitation of dysfunction of mitochondria isolated from rat brain in an anoxia-reoxygenation model. Life Sci 71 (2002) 3091-3108
31. Bertelli A.A.E., Giovannini L., De Caterina R., et al. Antiplatelet activity of cis-resveratrol. Drugs Exptl Cin Res 22 (1996) 61-63
32. Dobrydneva Y., Williams R.L., and Blackmore P.F. Trans-resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol 128 (1999) 149-157
33. Liew R., Stagg M.A., Macleod K.T., and Collins P. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur J Pharmacol 519 (2005) 1-8
34. Zhang Y., Liu Y., Wang T., et al. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 340 (2006) 1192-1199
35. Plin C., Tillement J.P., Berdeaux A., and Morin D. Resveratrol protects against cold ischemia-warm rexoxygenation-induced damages to mitochondria and cells in rat liver. Eur J Pharmacol 528 (2005) 162-168
36. Bråkenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB, Published online June 8, 2001.
37. Pellegatta F., Bertelli A.A.E., Staels B., et al. Different short- and long-term effects of resveratrol on nuclear factor-kB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 77 (2003) 1220-1228
38. Shen F., Chen S.J., Dong X.J., et al. Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res 5 (2003) 151-157
39. Cignarella A., Minici C., Bolego C., et al. Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr metab Cardiovasc Dis 16 (2006) 322-329
40. Renaud S., and de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
41. Bertelli A.A.E., Giovannini L., Giannessi D., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue Reac 17 (1995) 1-3
42. De Santi C., Pietrabissa A., Spisni R., Mosca F., and Pacifici G.M. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30 (2000) 609-617
43. De Santi C., Pietrabissa A., Mosca F., and Pacifici G.M. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30 (2000) 1047-1054
44. Romero-Pérez A.I., Lamuela-Raventós R.M., Waterhouse A.L., and de la Torre-Boronat M.C. Levels of cis- and trans-resveratrol and their glucosides in white and Rosé Vitis vinifera wines from Spain. J Agric Food Chem 44 (1996) 2124-2128
45. Chamkha M., Cathala B., Cheynier V., and Douillard R. Phenolic composition of champagnes from Cardonnay and Pinot Noir Vintages. J Agric Food Chem 51 (2003) 3179-3184
46. 3H]trans-resveratrol in rat tissues following oral administration. Brit J Nutr 96 (2006) 62-70
47. Urpí-Sardà M., Jáuregui O., Lamuela-Raventós R.M., et al. Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77 (2005) 3149-3155
48. Jannin B., Menzel M., Berlot J.P., et al. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 68 (2004) 1113-1118
49. de la Torre R., Covas M.I., Pujadas M.A., Fitó M., and Farré M. Is dopamine behind the health benefits of red wine?. Eur J Nutr 45 (2006) 307-310
50. Howitz K.T., Bitterman K.J., Cohen H.Y., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
51. Baur J.A., Pearson K.J., Price N.L., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
52. Kaeberlein M., McDonagh T., Heltweg B., et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280 (2005) 17038-17045
53. Zini R., Morin C., Bertelli A., Bertelli A.A.E., and Tillement J.P. Effrects of resveratrol on the rat brain respiratory chain. Drugs Exptl Clin Res 25 (1999) 87-97
54. Klatsky A.L., Friedman G.D., Armstrong M.A., and Kipp H. Wine, liquor, beer and mortality. Am J Epidemiol 158 (2003) 585-595
55. Whelan A.P., Sutherland W.H.F., McCormick M.P., et al. Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J 34 (2004) 224-228
56. Williams M.J.A., Sutherland W.H.F., Whelan A.P., McCormick M.P., and de Jong S.A. Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism 53 (2004) 318-323
57. Kikura M., lvey J.H., Safon R.A., Lee M.K., and Szlam F. The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers. Platelets 15 (2004) 37-41
58. Daher C.F., Slaiby R., Haddad N., Boustany K., and Baroody G.M. Effect of acute and chronic moderate red or white wine consumption on fasted and postprandial lipemia in the rat. J Toxicol Environ Health 69 (2006) 1117-1131
59. Bertelli A.A.E. Beneficial components of white wine. In: Preedy V.R., and Watson R.R. (Eds). Comprehensive handbook of alcohol related pathology (2005), Elsevier 389-392
60. Caccetta R.A.A., Croft K.D., Beilin L.J., and Puddey I.B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 71 (2000) 67-74
61. Bertelli A., Migliori M., Bertelli A.A.E., et al. Effect of some white wine phenols in preventing inflammatory cytokine release. Drugs Exptl Clin Res 28 (2002) 11-15
62. Betés-Saura C., Lacueva C.A., and Lamuela-Raventós R.M. Phenolics in white free run juices and wines from Penedès by high-performance liquid chromatography: changes during vinification. J Agric Food Chem (1996) 3040-3046
63. Bertelli A.A.E., Migliori M., Panichi V., et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann N Y Acad Sci 957 (2002) 295-301
64. Di Tommaso D., Calabrese R., and Rotilio D. Identification and quantitation of hydroxytyrosol in Italian Wines. J High Resol Chromatogr 21 (1998) 549-553
65. Wiseman S.A., Mathot J.N., de Fouw N.J., and Tijburg L.B. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis 120 (1996) 15-23
66. Covas M.I., de la Torre K., Albadejo M.F., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Rad Biology Med 46 (2006) 608-616
67. Covas M.I., Nyyssonen K., Poulsen H.E., et al., for the EUROLIVE study group. The effect of poplyphenols in olive oil on heart disease risk factors. A randomized trial. Ann Intern Med 145 (2006) 333-341
68. Bertelli A.A.E. Stockpiling of raw material for oseltamivir is not justified. BMJ 332 (2006) 178
69. Bianco A., Brufani M., Manna F., and Melchioni C. Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase. Carbohydrate Res 332 (2001) 23-31
70. Nielsen N.B., Schnohr P., Jensen G., and Gronbaek M. Is the relationship between type of alcohol and mortality influenced by socio-economic status?. J Intern Med 255 (2004) 280-288
71. Barefoot J.C., Gronboek M., Feaganes J.R., McPherson R.S., Williams R.B., and Siegler I.C. Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study. Am J Clin Nutr 76 (2002) 466-472
72. Wannamethee S.G., Camargo C.A., Manson J.E., Willett W.C., and Rimm E.B. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med 163 (2003) 1329-1336
73. Stender S., Dyerberg J., and Astrup A. High levels of industrially produced trans fat in popular fast foods. N Engl J Med 354 (2006) 1650-1652
74. Lesschaeve I., and Noble A.C. Polyphenols: factors influencing their sensory properties and their effects on food and beverage preferences. Am J Clin Nutr 81 suppl (2005) 330S-335S
75. Mukamal K.J., Cushman M., Mittleman M.A., Tracy R., and Siscovick D.S. Alcohol consumption and inflammatory markers in older adults: the cardiovascular health study. Atherosclerosis 173 (2004) 79-87
76. Mukamal K.J., Conigrave K.M., Mittleman M.A., et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348 (2003) 109-118
77. Marques-Vidal P., Montaye M., Haas B., et al. Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study. Atherosclerosis 157 (2001) 431-440
78. Estruch R., Sacanella E., Badia E., et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175 (2004) 117-123
79. The World Health Report 2002 page 66.
80. Cardiovascular disease risk factors: new areas for research. Report of a WHO scientific group, WHO Technical Report Series 841. Page 23, WHO, Geneva, 1994.